Company Description
DanCann Pharma A/S (DCPXF) is a Danish biopharmaceutical company founded in 2018, focusing on cannabinoid-powered products. Listed on the Spotlight Stock Market in Copenhagen/Stockholm and OTCQB in the USA, the company has recently published its Q2-2023 report, showcasing its growth and development in the industry.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Dancann Pharma A/S.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the market cap of Dancann Pharma A/S (DCPXF)?
The market cap of Dancann Pharma A/S (DCPXF) is approximately 39.9M. Learn more about what market capitalization means .
When was DanCann Pharma A/S founded?
DanCann Pharma A/S was founded in 2018.
Where is DanCann Pharma A/S listed?
DanCann Pharma A/S is listed on the Spotlight Stock Market in Copenhagen/Stockholm and side listed on OTCQB Venture Market in the USA.
What is the focus of DanCann Pharma A/S?
DanCann Pharma A/S focuses on developing cannabinoid-powered products in the biopharmaceutical industry.